what is glp-1 agonist You Should Know Before Asking for a Prescription GLP-1 Medications: Everything You Need
Description
Moreover, the SURMOUNTMMO (tirzepatide, NCT05556512) will assess the impact of the dual GLP-1/GIP RA in cardiovascular outcomes and all-cause mortality for people with obesity (without diabetes) when the REDEFINE-3 study will assess the impact of cagrisema in people with obesity (with and without T2DM) and established cardiovascular disease
Publication bias was minimised by comprehensive literature searching
GLP-1RAs have been shown to have beneficial effects on these factors
In: Bonora, E., DeFronzo, R
